{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T20:39:05Z","timestamp":1773779945160,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[1997,1,1]],"date-time":"1997-01-01T00:00:00Z","timestamp":852076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,16]],"date-time":"2019-08-16T00:00:00Z","timestamp":1565913600000},"content-version":"vor","delay-in-days":8262,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Japanese Journal of Pharmacology"],"published-print":{"date-parts":[[1997]]},"DOI":"10.1254\/jjp.60.317","type":"journal-article","created":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T17:53:00Z","timestamp":1606240380000},"page":"317-324","source":"Crossref","is-referenced-by-count":53,"title":["Cerebroprotective Effects of a Novel Pyrazoline Derivative, MS-153, on Focal Ischemia in Rats"],"prefix":"10.1016","volume":"73","author":[{"given":"Hiroshi","family":"Kawazura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshio","family":"Shiga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumiki","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norio","family":"Ohto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1254\/jjp.60.317_bib1","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/ana.410190202","article-title":"Glutamate and the pathophysiology of hypoxic-ischemia brain damage","volume":"10","author":"Rothman","year":"1986","journal-title":"Ann Neurol"},{"key":"10.1254\/jjp.60.317_bib2","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1523\/JNEUROSCI.07-02-00369.1987","article-title":"Ionic dependence of glutamate neurotoxicity","volume":"7","author":"Choi","year":"1987","journal-title":"J Neurosci"},{"key":"10.1254\/jjp.60.317_bib3","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1111\/j.1471-4159.1984.tb05396.x","article-title":"Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis","volume":"43","author":"Benveniste","year":"1984","journal-title":"J Neurochem"},{"key":"10.1254\/jjp.60.317_bib4","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0361-9230(90)90077-D","article-title":"Gerbil hippocampal extracellular glutamate and neuronal activity after transient ischemia","volume":"25","author":"Mitani","year":"1990","journal-title":"Brain Res Bull"},{"key":"10.1254\/jjp.60.317_bib5","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/jcbfm.1993.76","article-title":"Elevation of neuroactive substances in the cortex of cats during prolonged focal ischemia","volume":"13","author":"Matsumoto","year":"1993","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1254\/jjp.60.317_bib6","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/jcbfm.1989.87","article-title":"Dynamics of extracellular metabolites in the striatum after middle cerebral artery occlusion in the rat monitored by intracerebral microdialysis","volume":"9","author":"Hillered","year":"1989","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1254\/jjp.60.317_bib7","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/321519a0","article-title":"NMDA-receptor activation increases cytoplasmic calcium concentration in cultured spinal cord neurons","volume":"321","author":"MacDermott","year":"1986","journal-title":"Nature"},{"key":"10.1254\/jjp.60.317_bib8","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1476-5381.1986.tb11135.x","article-title":"Glutamate-induced increase in intracellular Ca++ concentration in isolated hippocampal neurones","volume":"89","author":"Kudo","year":"1986","journal-title":"Br J Pharmacol"},{"key":"10.1254\/jjp.60.317_bib9","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/jcbfm.1981.21","article-title":"Changes in extracellular calcium activity in cerebral ischemia","volume":"1","author":"Harris","year":"1981","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1254\/jjp.60.317_bib10","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1126\/science.164.3880.719","article-title":"Brain lesions, obesity and other disturbances in mice treated with monosodium glutamate","volume":"164","author":"Olney","year":"1969","journal-title":"Science"},{"key":"10.1254\/jjp.60.317_bib11","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1161\/01.STR.26.11.2187","article-title":"Massive persistent release of excitatory amino acid following human occlusive stroke","volume":"26","author":"Bullock","year":"1995","journal-title":"Stroke"},{"key":"10.1254\/jjp.60.317_bib12","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1161\/01.STR.24.7.1063","article-title":"BW619C89, a glutamate release inhibitor, protects against focal cerebral ischemic damage","volume":"24","author":"Leach","year":"1993","journal-title":"Stroke"},{"key":"10.1254\/jjp.60.317_bib13","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0014-2999(93)90804-Q","article-title":"Effect of rilu-zole on focal cerebral ischemia in rats","volume":"230","author":"Wlorence","year":"1993","journal-title":"Eur J Pharmacol"},{"key":"10.1254\/jjp.60.317_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-2999(92)90201-E","article-title":"The dose-response relationship and therapeutic window for dizocilpine (MK-801) in a rat focal ischaemia model","volume":"216","author":"Hatfield","year":"1992","journal-title":"Eur J Pharmacol"},{"key":"10.1254\/jjp.60.317_bib15","first-page":"1","article-title":"A dose-response study of neuroprotection using the AMPA antagonist NBQX in rat focal cerebral ischemia","volume":"276","author":"Graham","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1254\/jjp.60.317_bib16","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0021-5198(19)39850-6","article-title":"Nilvadipine, a new calcium channel blocker, reduces ischemic brain injury in rats","volume":"56","author":"Takakura","year":"1991","journal-title":"Jpn J Pharmacol"},{"key":"10.1254\/jjp.60.317_bib17","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1161\/01.STR.20.11.1531","article-title":"Nimodipine attenuates both increase in cytosolic free calcium and histologic damage following focal cerebral ischemia and reperfusion in cats","volume":"20","author":"Uematsu","year":"1989","journal-title":"Stroke"},{"key":"10.1254\/jjp.60.317_bib18","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/jcbfm.1995.75","article-title":"A selective N-type calcium channel antagonist reduces extracellular glutamate release and infarct volume in focal cerebral ischemia","volume":"15","author":"Takizawa","year":"1995","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1254\/jjp.60.317_bib19","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1161\/01.STR.27.9.1624","article-title":"Inhibitory effect of MS-153 on elevated brain glutamate level induced by the rat middle cerebral artery occlusion","volume":"27","author":"Umemura","year":"1996","journal-title":"Stroke"},{"key":"10.1254\/jjp.60.317_bib20","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0021-5198(19)47071-6","article-title":"Effect of MS-153, in ischaemic lesions in the rat middle cerebral artery occlusion model","volume":"67","author":"Kosuge","year":"1995","journal-title":"Jpn J Pharmacol"},{"key":"10.1254\/jjp.60.317_bib21","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/jcbfm.1981.6","article-title":"Focal cerebral ischemia in the rat: 1. Description of technique and early neuropathological consequences following middle cerebral artery occlusion","volume":"1","author":"Tamura","year":"1981","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1254\/jjp.60.317_bib22","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/jcbfm.1981.7","article-title":"Focal cerebral ischemia in the rat: 2. Regional cerebral blood flow determined by [14C]iodoantipyrine autoradiography following middle cerebral artery occlusion","volume":"1","author":"Tamura","year":"1981","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1254\/jjp.60.317_bib23","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/00004647-199601000-00013","article-title":"Short therapeutic window for MK-801 in transient focal ischemia in normotensive rats","volume":"16","author":"Margaill","year":"1996","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1254\/jjp.60.317_bib24","series-title":"Advances in Brain Resuscitation","first-page":"131","article-title":"Neurobehavioral changes following cerebral ischemia and treatment by a TRH derivative","author":"Tamura","year":"1991"},{"key":"10.1254\/jjp.60.317_bib25","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1161\/01.STR.17.3.472","article-title":"Rat middle cerebral artery occlusion: Evaluation of the model and development of a neurologic examination","volume":"17","author":"Bederson","year":"1986","journal-title":"Stroke"},{"key":"10.1254\/jjp.60.317_bib26","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1097\/00001756-199309150-00013","article-title":"Cerebroprotective effect of BW619C89 after focal or global ischemia in the rat","volume":"4","author":"Smith","year":"1993","journal-title":"Neuroreport"},{"key":"10.1254\/jjp.60.317_bib27","first-page":"854","article-title":"Neuroprotective effects of a use-dependent blocker of voltage-dependent sodium channels, BW619C89, in rat middle cerebral artery occlusion","volume":"269","author":"Graham","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1254\/jjp.60.317_bib28","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1161\/01.STR.17.6.1304","article-title":"Evaluation of 2,3,5-triphenyltetra-zolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats","volume":"17","author":"Bederson","year":"1986","journal-title":"Stroke"},{"key":"10.1254\/jjp.60.317_bib29","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/cne.901230302","article-title":"An experimental study of the anatomical organization of the cortico-bulbar system in the albino rat","volume":"123","author":"Zimmerman","year":"1964","journal-title":"J Comp Neurol"},{"key":"10.1254\/jjp.60.317_bib30","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1161\/01.STR.24.1.117","article-title":"Effect of brain edema on infarct volume in a focal cerebral ischemia model in rats","volume":"24","author":"Lin","year":"1993","journal-title":"Stroke"},{"key":"10.1254\/jjp.60.317_bib31","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1161\/01.STR.16.1.101","article-title":"Ischemic brain edema following occlusion of the middle cerebral artery in the rat. I: The time courses of the brain water, sodium and potassium contents and blood-brain barrier permeability to 125I-albu-min","volume":"16","author":"Gotoh","year":"1985","journal-title":"Stroke"},{"key":"10.1254\/jjp.60.317_bib32","first-page":"1","article-title":"A dose-response study of neuroprotection using the AMPA antagonist NBQX in rat focal cerebral ischemia","volume":"276","author":"Graham","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1254\/jjp.60.317_bib33","first-page":"43","article-title":"Cerebroprotective effect of a non-TV-methyl-D-aspartate antagonist, NBQX, after focal ischaemia in the rat","volume":"8","author":"Smith","year":"1993","journal-title":"Funct Neurol"}],"container-title":["Japanese Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021519819338028?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021519819338028?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T04:12:23Z","timestamp":1618459943000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021519819338028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997]]},"references-count":33,"aliases":["10.1254\/jjp.73.317","10.1254\/jjp.73.317"],"journal-issue":{"issue":"4","published-print":{"date-parts":[[1997]]}},"alternative-id":["S0021519819338028"],"URL":"https:\/\/doi.org\/10.1254\/jjp.60.317","relation":{},"ISSN":["0021-5198"],"issn-type":[{"value":"0021-5198","type":"print"}],"subject":[],"published":{"date-parts":[[1997]]}}}